• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, June 3, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

CU researchers provide resource for patient care in chemical and biological attacks

Bioengineer by Bioengineer
October 26, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

AURORA, Colo. (Oct. 26, 2018) – The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians.

"We wrote this article to help neurohospitalists and other health care providers identify unusual neurologic illnesses that could result from potential biological or chemical attacks," said senior author Daniel M. Pastula, MD, MHS. "While we hope such attacks never happen, our goal is to provide a resource for health care providers so that we can all be prepared in an emergency."

Pastula is an assistant professor in the CU School of Medicine's Department of Neurology and in the Department of Medicine's Division of Infectious Diseases, and an assistant professor of epidemiology at the Colorado School of Public Health.

The article, "Neuroterrorism Preparedness for the Neurohospitalist," published October 21 in the journal The Neurohospitalist, provides an overview of biological and chemical agents that might be used in potential terror attacks. Such agents can affect the nervous system and lead to paralysis, respiratory failure, and/or encephalopathy.

In the article, the authors describe how to recognize, diagnose, treat, and report exposures to anthrax, botulism, brucella, plague, smallpox, organophosphates, nerve agents, cyanide, or carfentanil.

"Our goal is to better prepare health care providers to clinically recognize and help manage potential effects of such agents. Additionally, we stress the importance of collaborating with state and local health departments when use of such agents is suspected." Pastula said.

###

In addition to Pastula, CU faculty who contributed to the article are Daniel Vela-Duarte, MD, assistant professor of neurology, and Karen D. Orjuela, MD, assistant professor of neurology. Collaborating co-authors were Maj. Samuel A. Ralston, DO, and Maj. Brian P. Murray, DO.

About the University of Colorado School of Medicine

Faculty at the University of Colorado School of Medicine work to advance science and improve care. These faculty members include physicians, educators and scientists at UCHealth University of Colorado Hospital, Children's Hospital Colorado, Denver Health, National Jewish Health, and the Veterans Affairs Eastern Colorado Health Care System. The school is located on the Anschutz Medical Campus, one of four campuses in the University of Colorado system.

Media Contact

Mark Couch
[email protected]
303-724-5377
@CUAnschutz

http://www.ucdenver.edu

http://dx.doi.org/10.1177/1941874418806668

Share12Tweet8Share2ShareShareShare2

Related Posts

MYOD1 Mutation Fuels Cancer Stemness, Therapy Resistance

June 3, 2026

Therapeutic Hypothermia Cuts Mortality in 35-Week Infants

June 3, 2026

Genetic and Cell-State Evolution in IDH Gliomas

June 3, 2026

Diverse Dynamics of Dengue-Specific CD8+ T Cells

June 3, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    321 shares
    Share 128 Tweet 80
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    87 shares
    Share 34 Tweet 22
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    69 shares
    Share 28 Tweet 17
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pediatric Insights from Recent Cell and Gene Therapies

MYOD1 Mutation Fuels Cancer Stemness, Therapy Resistance

Therapeutic Hypothermia Cuts Mortality in 35-Week Infants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.